1. Home
  2. SIDU vs TLSA Comparison

SIDU vs TLSA Comparison

Compare SIDU & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.69

Market Cap

159.0M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.34

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
TLSA
Founded
2012
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.0M
155.2M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
SIDU
TLSA
Price
$2.69
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.8M
129.0K
Earning Date
05-14-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
84.42
N/A
EPS
N/A
N/A
Revenue
$4,672,646.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.73
52 Week High
$5.39
$2.60

Technical Indicators

Market Signals
Indicator
SIDU
TLSA
Relative Strength Index (RSI) 60.12 44.40
Support Level $0.89 $1.27
Resistance Level $4.40 $1.59
Average True Range (ATR) 0.28 0.10
MACD 0.10 0.00
Stochastic Oscillator 65.76 30.00

Price Performance

Historical Comparison
SIDU
TLSA

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: